Stock Earnings

Question 1

How did REGN's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Regeneron Pharmaceuticals Inc is $11.83, not beating expectations of $9.77.

Question 2

How did Regeneron Pharmaceuticals Inc REGN's revenue perform in the last quarter?

Accepted Answer

Regeneron Pharmaceuticals Inc revenue for the last quarter is $11.83

Question 3

What is the revenue estimate for Regeneron Pharmaceuticals Inc?

Accepted Answer

According to 24 of Wall street analyst, the revenue estimate of Regeneron Pharmaceuticals Inc range from $4.31B to $3.34B

Question 4

What's the earning quality score for Regeneron Pharmaceuticals Inc?

Accepted Answer

Regeneron Pharmaceuticals Inc has a earning quality score of A-/68.26352. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Regeneron Pharmaceuticals Inc report earnings?

Accepted Answer

Regeneron Pharmaceuticals Inc next earnings report is expected in 2026-01-26

Question 6

What are Regeneron Pharmaceuticals Inc's expected earnings?

Accepted Answer

Regeneron Pharmaceuticals Inc expected earnings is $3.65B, according to wall-street analysts.

Question 7

Did Regeneron Pharmaceuticals Inc beat earnings expectations?

Accepted Answer

Regeneron Pharmaceuticals Inc recent earnings of $3.75B beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$9.77	$11.83	+21.08%	BEAT
Q2 '25	$8.6	$12.89	+49.88%	BEAT
Q1 '25	$8.99	$8.22	-8.56%	MISSED
Q4 '24	$11.5	$12.07	+4.95%	BEAT
Q3 '24	$11.92	$12.46	+4.53%	BEAT

Regeneron Pharmaceuticals Inc (REGN) Price

REGN Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ